ARIH2 Ubiquitination Regulates NUPR1 to Inhibit Ferroptosis in Bladder Cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Nuclear protein 1 (NUPR1) is a known pro-tumorigenic factor in bladder cancer (BLCA).
• The precise mechanisms regulating NUPR1 protein stability in BLCA are not fully understood.
• Understanding these regulatory mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

• To identify the E3 ubiquitin ligase responsible for NUPR1 regulation in BLCA.
• To elucidate the functional role of the ARIH2-NUPR1 interaction in BLCA progression.
• To investigate the impact of this regulatory axis on ferroptosis and the tumor microenvironment.

Main Methods:

• Immunoprecipitation-mass spectrometry (IP-MS) and co-immunoprecipitation (Co-IP) to identify interacting proteins.
• Immunofluorescence assays to confirm protein localization and interaction.
• Overexpression and knockdown studies to assess functional consequences.
• Analysis of ferroptosis markers (GPX4, SLC7A11, ACSL4, lipid peroxidation, Fe2+ accumulation).
• Bioinformatic and experimental evaluation of immune cell infiltration and macrophage polarization.

Main Results:

• ARIH2 was identified as an E3 ubiquitin ligase that interacts with and targets NUPR1 for degradation in BLCA cells.
• ARIH2 overexpression reduced NUPR1 levels, inhibiting cell proliferation and migration while promoting apoptosis.
• NUPR1 overexpression suppressed ferroptosis, whereas NUPR1 knockdown promoted it.
• ARIH2 modulated ferroptosis, likely through its regulation of NUPR1.
• NUPR1 was linked to immunosuppression and M2 macrophage polarization.

Conclusions:

• The study uncovers a novel ARIH2-NUPR1 regulatory axis in BLCA.
• This axis drives tumor progression by suppressing ferroptosis and fostering an immunosuppressive microenvironment.
• Targeting the ARIH2-NUPR1 pathway presents a potential therapeutic strategy for BLCA.